According to the company, the malaria drug Artemisinin is scheduled for a third-quarter launch in 2009, and HIV/AIDS pharmaceuticals are in process.
Mulugetta Bezzabeh, CEO of Rx for Africa, Inc said: “Our launch list of generic pharmaceuticals includes many standard antibiotics, anti-fungals, anti-inflammatory and analgesic drugs that are taken for granted in the US and developed world, but of which there are still extreme shortages in Ethiopia, and throughout Sub-Saharan Africa.
“Our staff in Ethiopia, including scientists from India and Germany, is now accomplishing this important work and meeting or exceeding scheduling milestones.”